1 Min Read
* Takeda announces FDA approval of ALUNBRIG (brigatinib) 180 mg tablets
* Takeda Pharmaceutical Co Ltd - 180 mg tablets and previously approved 90 mg tablets will be available later this year Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.